Hoya transfers MID Labs shares while Hoya stock trades at EUR 146.10

Published on 10/20/2026 at 10:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HOYA will transfer MID Labs to Bausch + Lomb on November 2, 2026. Hoya stock costs EUR 146.10 on October 20, 2026.

Medical portfolio changes

HOYA agreed on October 9, 2026, to transfer MID Labs to Bausch + Lomb with an 88 percent stake.
First-quarter fiscal 2027 revenue reached JPY 255.742 billion, up 16.0 percent year over year.
Hoya stock traded at EUR 146.10 at 9:47 a.m. CEST at Lang & Schwarz on October 20, 2026.
HOYA's next results are scheduled for October 30, 2026.

Hoya, JP3837800006, Illustration mit AI erstellt.

Hoya Corporation stock traded at EUR 146.10 at Lang & Schwarz on October 20, 2026, at 9:47 a.m. CEST. The latest corporate action is a planned transfer of its MID Labs subsidiary to Bausch + Lomb, giving the buyer an 88 percent stake, according to Japan IR on October 9, 2026.

MID Labs leaves the group

The transaction changes the shape of HOYA's medical portfolio rather than adding a new business. The company will transfer all 3,648,539 MID Labs shares, while the delivery is scheduled for November 2, 2026. HOYA expects only a minor effect on consolidated results, according to Japan IR.

The deal follows a strong first quarter. Revenue for the quarter ended June 30, 2026, reached JPY 255.742 billion, up 16.0 percent from a year earlier, while operating profit rose to JPY 82.626 billion, up 30.0 percent, according to Smart Stock Notes. The reported growth gives the portfolio decision a different context: HOYA is reshaping selected medical assets while the wider group is expanding.

What comes next for results?

The next scheduled reporting date is October 30, 2026, when HOYA is expected to publish results for the quarter ended September 30, 2026. Current estimates cited by Finanzen put quarterly revenue at JPY 263.68 billion, which would be 12.45 percent above the year-earlier period. That estimate is a market expectation, not a reported result.

Three dated steps in the strategy

On April 30, 2026, HOYA reported fiscal-year revenue of JPY 947.7 billion. On July 31, 2026, it reported first-quarter fiscal 2027 revenue of JPY 255.742 billion, up 16.0 percent year over year. On October 9, 2026, it agreed to transfer MID Labs and 3,648,539 shares to Bausch + Lomb, according to Japan IR.

Stock and company facts

HOYA is valued at JPY 8.7 trillion on the Tokyo market as of October 20, 2026. Its 52-week range is JPY 22,165.00 to JPY 30,400.00, and the company operates across healthcare and medical instruments as well as optical and semiconductor-related products.